Free Trial

Small Cap Stocks To Follow Now - June 24th

ProShares UltraPro Short QQQ logo with background

ProShares UltraPro Short QQQ, BigBear.ai, AltC Acquisition, Nektar Therapeutics, and Spring Valley Acquisition are the five Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are the publicly traded shares of companies whose total market capitalization generally falls between about $300 million and $2 billion. Because these firms are smaller and less established, their shares can offer higher growth potential but also tend to be more volatile and less liquid than those of larger companies. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Shares of NASDAQ SQQQ traded down $1.03 during mid-day trading on Tuesday, reaching $21.09. 67,997,145 shares of the company traded hands, compared to its average volume of 62,657,857. ProShares UltraPro Short QQQ has a fifty-two week low of $21.03 and a fifty-two week high of $57.95. The stock has a fifty day simple moving average of $26.99 and a 200-day simple moving average of $30.53.

Read Our Latest Research Report on SQQQ

BigBear.ai (BBAI)

BigBear.ai Holdings, Inc. provides artificial intelligence-powered decision intelligence solutions. It offers national security, supply chain management, and digital identity and biometrics solutions. The company also provides data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics, and predictive visualization solutions and services.

Shares of BigBear.ai stock traded up $0.93 on Tuesday, reaching $5.11. 262,788,647 shares of the company were exchanged, compared to its average volume of 41,398,522. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.55. BigBear.ai has a fifty-two week low of $1.17 and a fifty-two week high of $10.36. The firm has a market capitalization of $1.49 billion, a price-to-earnings ratio of -6.55 and a beta of 3.30. The stock has a fifty day moving average price of $3.54 and a 200-day moving average price of $4.03.

Read Our Latest Research Report on BBAI

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

ALCC traded down $2.84 on Tuesday, reaching $55.11. 19,045,026 shares of the company traded hands, compared to its average volume of 723,393. The stock's 50 day moving average price is $39.74 and its 200-day moving average price is $33.18. AltC Acquisition has a 52-week low of $10.27 and a 52-week high of $18.80.

Read Our Latest Research Report on ALCC

Nektar Therapeutics (NKTR)

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 2b clinical trial to treat atopic dermatitis and psoriasis; and NKTR-255, an IL-15 receptor agonist, which is in phase 1 clinical trial to boost the immune system's natural ability to fight cancer.

Shares of NASDAQ:NKTR traded up $15.68 during midday trading on Tuesday, hitting $25.22. The company's stock had a trading volume of 29,125,785 shares, compared to its average volume of 269,408. Nektar Therapeutics has a fifty-two week low of $6.48 and a fifty-two week high of $26.54. The stock's 50 day simple moving average is $10.09 and its 200 day simple moving average is $11.84. The stock has a market capitalization of $312.98 million, a price-to-earnings ratio of -2.63 and a beta of 0.55.

Read Our Latest Research Report on NKTR

Spring Valley Acquisition (SV)

Shares of Spring Valley Acquisition stock traded down $0.70 during mid-day trading on Tuesday, reaching $36.50. 12,979,152 shares of the stock were exchanged, compared to its average volume of 530,580. Spring Valley Acquisition has a fifty-two week low of $8.56 and a fifty-two week high of $11.23. The firm has a 50-day simple moving average of $25.49 and a 200 day simple moving average of $21.71.

Read Our Latest Research Report on SV

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ProShares UltraPro Short QQQ Right Now?

Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.

While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines